1
Tarran Jones
Chesnut Robert W, Polley Margaret J, Paulson James C, Jones S Tarran, Saldanha Jose W, Bendig Mary M, Kriegler Michael, Perez Carl, Bayer Robert, Nunn Michael: Antibodies to p-selectin and their uses. Cytel, November 5, 1997: EP0804235-A1

The present invention relates to compositions and methods for treating inflammation and other pathological conditions using novel blocking P-selectin antibodies that inhibit adhesion of leukocytes to activated platelets and/or to activated vascular endothelium in vivo. Both murine and humanized anti ...


2
Chestnut Robert W, Polley Margaret J, Paulson James C, Bayer Robert: Antibodies to p-selectin and their uses.. Cytel, March 15, 1995: EP0642356-A1

The present invention relates to compositions and methods for treating inflammation and other pathological conditions using novel blocking P-selectin antibodies which inhibit binding of an antibody secreted by a cell line designated ATCC Accession No. HB11041 to P-selectin as measured by a competiti ...


3
Chestnut Robert W, Polley Margaret J, Paulson James C, Bayer Robert: Anticorps de la p-selectine et leur utilite, Antibodies to p-selectin and their uses. Cytel Corporation, Aeres Biomedical, FETHERSTONHAUGH & CO, November 11, 1993: CA2135083

The present invention relates to compositions and methods for treating inflammation and other pathological conditions us-ing novel blocking P-selectin antibodies which inhibit binding of an antibody secreted by a cell line designated ATCC Accession No. HB11041 to P-selectin as measured by a competit ...


4
Chestnut Robert W, Polley Margaret J, Paulson James C, Bayer Robert: Antibodies to p-selectin and their uses. Cytel Corporation, Chestnut Robert W, Polley Margaret J, Paulson James C, Bayer Robert, SMITH William M, November 11, 1993: WO/1993/021956

The present invention relates to compositions and methods for treating inflammation and other pathological conditions using novel blocking P-selectin antibodies which inhibit binding of an antibody secreted by a cell line designated ATCC Accession No. HB11041 to P-selectin as measured by a competiti ...


5
Chestnut Robert W, Polley Margaret J, Paulson James C: Antibody against p-selectin and utilization thereof. Aeres Biomedical, February 16, 2006: JP2006-045234

PROBLEM TO BE SOLVED: To provide a new antibody against P-selectin associated with the inhibition of cell adhesion by using a new immunoglobulin reacting with a functional epitope on the P-selectin (CD62, granule membrane protein-140 (GMP-140)/platelet-activation-depending granule envelope (PADGEM)/ ...


6
Tarran Jones
Chesnut Robert W, Polley Margaret J, Paulson James C, Jones S Tarran, Saldanha Jose W, Bendig Mary M, Kriegler Michael, Perez Carl, Bayer Robert, Nunn Michael: Anticorps pour la p-selectine et leurs utilisations, Antibodies to p-selectin and their uses. Cytel Corporation, Aeres Biomedical, GOWLING LAFLEUR HENDERSON, November 10, 1994: CA2162149

The present invention relates to compositions and methods for treating inflammation and other pathological conditions using novel blocking P-selectin antibodies that inhibit adhesion of leukocytes to activated platelets and/or to activated vascular endothelium in vivo. Both murine and humanized anti ...


7
Tarran Jones
Chesnut Robert W, Polley Margaret J, Paulson James C, Jones S Tarran, Saldanha Jose W, Bendig Mary M, Kriegler Michael, Perez Carl, Bayer Robert, Nunn Michael: Antibodies to p-selectin and their uses. Cytel Corporation, Chesnut Robert W, Polley Margaret J, Paulson James C, Jones S Tarran, Saldanha Jose W, Bendig Mary M, Kriegler Michael, Perez Carl, Bayer Robert, Nunn Michael, CAMPBELL Cathryn, November 10, 1994: WO/1994/025067

The present invention relates to compositions and methods for treating inflammation and other pathological conditions using novel blocking P-selectin antibodies that inhibit adhesion of leukocytes to activated platelets and/or to activated vascular endothelium $i(in vivo). Both murine and humanized ...